New approach to B-ALL treatment reduces side effects and enhances survival
Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).
25 Sep 01:46 · News-Medical